Here’s what you should know:
1. Crospon created the EndoFLIP, a device that provides gastroenterologists an internal view of the oesophagus.
2. Medtronic will integrate Crospon into its respiratory, gastrointestinal and informatics business.
3. In a LinkedIn post, Crospon CEO John O’Dea said, “We are delighted to have EndoFLIP today become part of Medtronic’s industry-leading gastrodiagnostic platform sitting alongside category leaders such as Manoscan, Pillcam, SmartPill, Bravo, and Digitrapper. We look forward to an emerging future where index endoscopy, allied with innovative diagnostics, can improve diagnostic yield to reduce time to treatment.”
4. While Crospon had losses close to €13 million ($15.35 million) in 2016, the device maker was growing with estimated revenues close to 8 percent in 2016. Analysts expected the company’s revenues to hit 30 percent in 2017, FORA reports. Crospon, a privately held company, didn’t publish sales figures prior to the acquisition.
More articles on gastroenterology:
Mayo Clinic kicks off $65M surgical suite expansion — building 14 ORs, GI endoscopy center
Colonoscopy price for 30 largest US cities
The 20 states with the best and worst colorectal cancer screening rates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.